Quick Answer
Atea Pharmaceuticals, Inc. reported Total Assets of $315.22 million for fiscal year 2025.
Atea Pharmaceuticals, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $315.22M | -32.2% |
| 2024 | $464.67M | -21.9% |
| 2023 | $594.97M | -10.8% |
| 2022 | $666.71M | -13.7% |
| 2021 | $772.89M | -10.5% |
| 2020 | $863.63M | +3812.6% |
| 2019 | $22.07M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $342.96M | -30.1% | -12.4% |
| June 30, 2025 | $391.61M | -23.3% | -11.0% |
| March 31, 2025 | $439.96M | -20.4% | -5.3% |
| December 31, 2024 | $464.67M | -21.9% | -5.4% |
| September 30, 2024 | $490.96M | -19.3% | -3.8% |
| June 30, 2024 | $510.38M | -18.5% | -7.7% |
| March 31, 2024 | $553.03M | -13.3% | -7.0% |
| December 31, 2023 | $594.97M | -10.8% | -2.2% |
- Atea Pharmaceuticals, Inc. showed a decrease of -32.2% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Atea Pharmaceuticals, Inc.’s total assets has grown by 1328.1% (from $22.07 million to $315.22 million).
- The most recent figure is from Atea Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: